A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/1993
12/23/1993	WO1993025673A1 In vivo gene therapy with intron-free sequence of interest
12/23/1993	WO1993025665A1 Recombinant herpesvirus of turkeys and uses thereof
12/23/1993	WO1993025661A1 Heterogeneous proteolipid peptide 139-151-specific t cell clones
12/23/1993	WO1993025583A2 Proteinoid carriers and methods for preparation and use thereof
12/23/1993	WO1993025582A1 A novel endothelial cell molecule mediating lymphocyte binding in man
12/23/1993	WO1993025577A2 Active component of parathyroid hypertensive factor
12/23/1993	WO1993025575A1 Peptide for stimulation of cytotoxic t lymphocytes specific for hepatitis c virus
12/23/1993	WO1993025572A1 T-cell monocyte inducing proteins (tmips)
12/23/1993	WO1993025240A2 Pretargeting methods and compounds
12/23/1993	WO1993025237A1 Chimeric anti-cea antibody
12/23/1993	WO1993025236A1 Humoral immunity and cell mediation adjuvant composition inducing no response to auto-antigenic determinants
12/23/1993	WO1993025233A1 Contraceptive vaccine
12/23/1993	WO1993025232A1 The use of hyperimmune milk to increase longevity
12/23/1993	WO1993025231A1 Use of zona pellucida glycoproteins for immunocontraception
12/23/1993	WO1993025210A1 Diphtheria toxin vaccines
12/23/1993	WO1993017031A3 Nucleic acids encoding dystrophin-associated proteins
12/23/1993	CA2138151A1 New polypeptides with a nmda receptor activity, nucleic acid coding for these polypeptides and their use
12/23/1993	CA2138146A1 Proteinoid carriers and methods for preparation and use thereof
12/23/1993	CA2138038A1 Recombinant production of saporin-containing proteins
12/23/1993	CA2137930A1 Recombinant herpesvirus of turkeys and uses thereof
12/23/1993	CA2137829A1 Active component of parathyroid hypertensive factor
12/23/1993	CA2137656A1 Monoclonal antibody
12/23/1993	CA2137571A1 Humoral immunity and cell mediation adjuvant composition inducing no response to auto-antigenic determinants
12/23/1993	CA2137547A1 Chimeric receptor polypeptides, human h13 proteins and uses thereof
12/23/1993	CA2137077A1 Contraceptive vaccine
12/23/1993	CA2136724A1 Recombinant pseudomonas exotoxin with increased activity
12/23/1993	CA2136641A1 The use of hyperimmune milk to increase longevity
12/23/1993	CA2135397A1 T-cell membrane inducing factors
12/23/1993	CA2134752A1 Monoclonal antibodies to glycoprotein p
12/23/1993	CA2115346A1 Chimeric anti-cea antibody
12/22/1993	EP0574955A1 Production and use of IL-6
12/22/1993	EP0574579A1 Dna encoding a human 5-ht 1f? receptor and uses thereof
12/22/1993	EP0574575A1 Method for isolating biomolecules with linear polymers
12/22/1993	EP0574512A1 Redirection of cellular immunity by receptor chimeras
12/22/1993	EP0574466A1 Expression of recombinant proteins in attenuated bacteria
12/22/1993	EP0574461A1 High affinity humanized monoclonal antibodies
12/22/1993	EP0574395A1 Cytokine immunoconjugates
12/22/1993	EP0574391A1 Antibodies against the urokinase receptor and their use
12/22/1993	EP0383777B1 HUMAN ANTI-Rh(D) MONOCLONAL ANTIBODIES
12/22/1993	EP0351406B1 Agent preventing the development of disease after hiv infection
12/22/1993	EP0315682B1 Avirulent microbes and uses therefor
12/22/1993	CN1079825A Immunochemical detection of in vivo advanced glycosylation endproducts
12/21/1993	US5272263 DNA sequences encoding vascular cell adhesion molecules (VCAMS)
12/21/1993	US5272253 Cluster conjugates of drugs with antibodies
12/21/1993	US5272176 Advanced glycation inhibitors containing amino-benzoic acids and derivatives, and methods of use
12/21/1993	US5272165 2-alkylidene-aminoguanidines and methods of use therefor
12/21/1993	US5272058 Diagnostic methods for E. histolytica
12/21/1993	US5272055 Detection of Alzheimer's disease and other diseases using a photoaffinity labeling method
12/20/1993	CA2098448A1 Dna fragments which encode the transferrin receptor subunits of neisseria meningitidis
12/18/1993	CA2084136A1 Design, construction and expression of chimeric proteins for development of vaccines and diagnostic reagents
12/15/1993	EP0573616A1 RECOMBINANT FIV GLYCOPROTEIN 160 AND p24 GAG PROTEIN
12/15/1993	EP0573614A1 Attenuated, genetically-engineered pseudorabies virus s-prv-155 and uses thereof
12/15/1993	EP0573545A1 Monoclonal antibodies against receptor-induced binding sites
12/15/1993	EP0573527A1 Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e. coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e. coli bacteria in humans
12/15/1993	EP0573510A1 Anti-growth factor antibodies in the treatment of vascular stenosis
12/15/1993	EP0377722B1 Method for the treatment and the diagnosis of coronary heart disease
12/15/1993	CN1079509A HIV antigen
12/15/1993	CN1079400A Anti-tumor method and anti-tumor agent
12/14/1993	US5270171 Cancer-associated SCM-recognition factor, preparation and method of use
12/14/1993	US5270165 Method of diagnosis of amyloidoses
12/14/1993	US5270038 Tumor necrosis factor receptors on microorganisms
12/14/1993	CA1325193C Class i mhc modulation of surface receptor activity
12/14/1993	CA1325192C Cell-associated glucosyltransferase, an antibody thereto, and a dental caries prophylactic composition containing said antibody as an effective component
12/09/1993	WO1993024647A1 Anti-idiotypic monoclonal antibodies against the lewis y-specific monoclonal antibody br55-2 and their uses
12/09/1993	WO1993024646A1 Fowl mycoplasma antigen, gene thereof, recombinant vector containing said gene, and vaccine prepared by utilizing the same
12/09/1993	WO1993024640A2 Methods and compositions for in vivo gene therapy
12/09/1993	WO1993024636A1 Use of protein oprf for bacterial cell surface expression of oligopeptides
12/09/1993	WO1993024617A1 Human virus associated with chronic fatigue immune deficiency syndrome (cfids) and assay therefor
12/09/1993	WO1993024616A1 Process for attenuated varicella zoster virus vaccine production
12/09/1993	WO1993024614A1 Antibodies with specificity for multiple adhesion molecules
12/09/1993	WO1993024528A1 Equine herpesvirus glycoproteins
12/09/1993	WO1993024525A1 PEPTIDES OF HUMAN p53 PROTEIN FOR USE IN HUMAN T CELL RESPONSE INDUCING COMPOSITIONS, AND HUMAN p53 PROTEIN-SPECIFIC CYTOTOXIC T-LYMPHOCYTES
12/09/1993	WO1993024148A1 Combined vaccines comprising hepatitis b surface antigen and other antigens
12/09/1993	WO1993024147A1 Lecithin adjuvanted modified live virus vaccines
12/09/1993	WO1993024146A1 Anti-haemophilus influenza immunoprotein
12/09/1993	WO1993024145A1 Compositions useful in diagnosis and prophylaxis of lyme disease
12/09/1993	WO1993024139A1 Antibiotic cryptdin peptides and methods of their use
12/09/1993	WO1993024136A1 Tumor killing effects of enterotoxins, superantigens, and related compounds
12/09/1993	WO1993024000A1 Methods for obtaining and purifying cell-free pneumococcal surface proteins from s. pneumoniae and use thereof
12/09/1993	WO1993021963A3 Carboxamide modified polyamine chelators and radioactive complexes and conjugation
12/09/1993	WO1993014750A3 Amino acids useful as inhibitors of the advanced glycosylation of proteins
12/09/1993	CA2136857A1 Cryptosporidium polypeptides, nucleic acid, vectors and methods of use
12/09/1993	CA2136624A1 Peptides of human p53 protein for use in human t cell response inducing compositions, and human p53 protein-specific cytotoxic t-lymphocytes
12/09/1993	CA2136016A1 Lecithin adjuvanted modified live virus vaccines
12/09/1993	CA2135800A1 Compositions useful in diagnosis and prophylaxis of lyme disease
12/09/1993	CA2134773A1 Methods and compositions for in vivo gene therapy
12/08/1993	EP0573107A2 Process for attenuated varicella zoster virus vaccine production
12/08/1993	EP0572737A2 HIV Gag-env fusion antigen
12/08/1993	EP0572573A1 Thyroid-derived chondrocyte-stimulating factor
12/08/1993	EP0572553A1 Recombinant thrombin receptor and related pharmaceuticals
12/08/1993	EP0572478A1 A method for the diagnosis and treatment of glutamic acid decarboxylase autoantigen associated diseases
12/08/1993	EP0572443A1 Suppression of immune responses with oligomeric forms of antigen of controlled chemistry
12/08/1993	EP0572433A1 Antigen-presenting capsid with fusion ms2-coat protein
12/08/1993	EP0417129B1 Lung growth stimulatory and inhibitory factors for carcinoma tumor cells
12/08/1993	EP0267204B1 Immunopotentiation
12/08/1993	EP0261224B1 Synthetic htlv-iii peptides, compositions and uses thereof
12/08/1993	CN1079166A Use of interleukin-10 to suppress graft-VS.-host disease
12/07/1993	US5268454 Composition for inducing humoral anergy to an immunogen comprising a t cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic carrier
12/07/1993	US5268364 Block addition of a serine or threonine residue to protein
12/07/1993	US5268265 Immunological complex comprising an antigen of Simian Immunodeficiency Virus (SIV) and an antibody against human immunodeficiency virus type 2 (HIV 2), and method and kit for detecting antibodies to HIV-2 reactive with antigens of SIV

1 ... 1695 1696 1697 1698 1699 1700 1701 1702 1703 1704 1705 1706 1707 1708 1709 1710 1711 1712 1713 1714 1715 ... 1823